The non-pathogenic lizard-infecting protozoan Leishmania (Sauroleishmania) tarentolae is used currently as a safe model for mammal-infecting Leishmania species. It is also a useful alternative organism for the expression of accurately-modified heterologous eukaryotic proteins. A short doubling-time and simple nutrient requirements (Simpson & Braly 1970) make L. tarentolae an attractive host for high level production of heterologous proteins containing N-linked oligosaccharide modifications similar to those found in mammals (Breitling et al. 2002 , Kushnir et al. 2005 , and for generating isotopically-labeled protein for nuclear magnetic resonance studies (Niculae et al. 2006) . In addition, L. tarentolae can be used as a live vaccine capable of eliciting protective immune response against L. (Leishmania) donovani, opening a new avenue for vaccination against other species involved in cutaneous leishmaniasis without the risk of disease development in humans (Breton et al. 2005) . These preliminary results open up the perspective of dramatic improvements in the immunity response by vaccination with a nonpathogenic organism expressing an antigenic recombinant protein. Thus, efficient vectors and expression strategies are essential tools for the employment of L. tarentolae as recipient vessels for production of recombinant proteins with prophylactic promise.
A particular biological feature of Kinetoplastidae species is the polycistronic transcription of protein-coding genes followed by trans-splicing, and regulation of gene expression almost exclusively at the post-transcriptional level (Clayton 2002 , Campbell et al. 2003 , Mayer & Floeter-Winter 2005 . Unlike most eukaryotes, almost all trypanosomatid protein-coding genes are transcribed constitutively as polycistronic pre-mRNAs from a few non-conventional RNA polymerase (RNA pol) II promoter regions (Palenchar & Bellofatto 2006) . Two linked events in the intergenic region convert polycistronic to monocistronic mRNA. The trans-splicing of a pre-capped 39-nt spliced leader (a.k.a. the mini-exon) onto the pre-mRNA is initiated at an AG downstream of a polypyrimidine tract; the second event is the polyadenylation of the upstream mRNA. As a result, a large number of mature mRNAs are produced from a single transcription initiation event (Mayer & FloeterWinter 2005) . Since transcription and pre-mRNA processing are uncoupled events, exogenous protein-coding genes can be transcribed by the endogenous RNA pol I (Tyler-Cross et al. 1995 , Uliana et al. 1996 or by an introduced polymerase, e.g. T7 RNA pol (Wirtz et al. 1998) . This particularity allows the use of strong RNA pol I promoters for the production of recombinant proteins in a variety of kinetoplastids (Martinez-Calvillo et al. 1997, Downey and Donelson 1999) . The ribosomal RNA promoter imparts stability to plasmid inheritance in Leishmania (Boucher et al. 2004 ) and may thus be beneficial to long-term protein expression. The generally-accepted paradigm is that ribosomal RNA promoters show species specificity in their ability to direct transcription by RNA pol I (Jacob & Ghosh 1999 , Grummt 1999 In this regard, we have proposed the existence of regulation carried out by a repressor in the region upstream of the promoter for the considered species. In addition, differential recognition of RNA processing signals could influence expression levels. The mRNA maturation signals in trypanosomatids consist of a polypyrimidine tract upstream of an AG dinucleotide, marking the point for mini-exon addition by trans-splicing (Mayer & FloeterWinter 2005) . It is also known that the size of the tract and its distance to the AG are essential to the efficiency of the process (Curotto de Lafaille et al. 1992 , Benz et al. 2005 , Siegel et al. 2005 .
To evaluate the effect of the polypyrimidine tract and cross recognition of the RNA pol I promoter, we constructed two expression vectors using chloramphenicol acetyl transferase (CAT) as reporter, directed by the RNA pol I promoter region from L. tarentolae, but differing only in relation to the polypyrimidine tract in the splice acceptor site. The expression of CAT was also evaluated in relation to the host receiving both episomes. Pathogenic and nonpathogenic Leishmania species were transfected, with L. tarentolae the homologous host and other Leishmania species as heterologous hosts.
Initially, we constructed the vector pAB3.0stCAT, using an approximately 3-kb genomic fragment from the ribosomal DNA L. tarentolae intergenic spacer and external transcribed spacer (IGS/ETS) that encompasses the RNA pol I promoter region (Orlando et al. 2002) , followed by a synthetic splice acceptor site (st) based on L. major hsp70 gene (Uliana et al. 1996) to drive expression of the CAT gene reporter (Fig. 1) . To determine the host range of promoter activity, transient transfection experiments and CAT activity assays were performed as described (Uliana et al. 1996 ) using lizardinfecting host cells L. tarentolae and L. (S.) hoogstraali, and the pathogenic mammalian infecting L. amazonensis. Surprisingly, no CAT activity was detected in any Leishmania species analyzed (Fig. 2) . Interestingly, the same synthetic acceptor site 'st' sequence had already been efficiently used for L. amazonensis with the L. amazonensis ribosomal RNA promoter (Uliana et al. 1996 , de Andrade Stempliuk & Floeter-Winter 2002 . Although likely to be functional in the L. major hsp70 pre-mRNA, we suspected that the short polypyrimidine tract used in pAB3.0stCAT (3 from the ETS plus 13 from the st, see Fig. 1C -2) could be responsible for the failure of gene reporter expression by abolishing or lowering trans-splicing of the CAT gene. It is notable that in the 3' end of L. amazonensis ETS the number of pyrimidines is higher (9, instead of 3, see Fig. 1C-1) , as possible explanation for the efficiency of that construct. We constructed another vector, pAB3.0tbCAT, replacing the synthetic acceptor site by the splice acceptor site (tb) of Trypanosoma brucei EP1 (or PARP B) gene (Sherman et al. 1991) , which contains a longer polypyrimidine tract (3 from the ETS plus 28 from tb, see Fig. 1C-3) , positioned upstream the CAT gene. In addition, the tb sequence presents more than one AG that can assure the occurrence of trans-splicing, a fact already observed for other trypanosomatid genes (Mayer & Floeter-Winter 2005) . Transient transfection of the same Leishmania species with pAB3.0tbCAT showed positive expression results (Fig. 2) .
Since the most obvious difference between the plasmids is the length of the polypyrimidine tracts, we speculate that additional runs of pyrimidines (Fig 1B, boxed) in the L. amazonensis promoter region may have enabled expression in the homologous transfection. Moreover, CAT activity in heterologous lizard-infecting species L. hoogstraali was 4.5 fold higher than observed in the homologous species, indicating that expression driven (Orlando et al. 2002) ; B: schematic of plasmids: the two constructions containing the L. tarentolae IGS/ ETS (white box) upstream to the synthetic (st) or to T. brucei derived (tb) splice acceptor site followed by CAT coding sequence (gray box); C: sequence of ETS/acceptor site junction of the plasmid constructions. 1: construct pLa∆14ASCAT: 3'end of L. (Leishmania) amazonensis ETS-synthetic splice acceptor site (Uliana et al., 1996) ; 2: construct pAB3.0stCAT: 3' end of L. tarentolae ETS-synthetic splice acceptor site; 3: construct pAB3.0tbCAT: 3'end of L. tarentolae ETS-T. brucei derived splice acceptor site (Sherman et al. 1991) . Normal characters correspond to the ETS sequence; boxes indicate additional run of pyrimidines in the 3'ETS; letters after the dash indicate the polypyrimidine tract and splice acceptor site with AG indicated by underlining.
by the RNA pol I promoter is up-regulated in heterologous lizard-Leishmania species. In contrast, the CAT expression detected in the distant relative human-pathogenic L. amazonensis transfected with that construct was approximately half that in the homologous species (Fig. 2) .
We extended the study of heterologous expression systems by transfecting two other lizard-infecting nonpathogenic Leishmania with construct pAB3.0tbCAT. L. (S.) gymnodactyli and L. (S.) adleri presented a CAT expression higher than the CAT level determined for the homologous L. tarentolae (Fig. 3) . A more recent isolate of L. tarentolae, LEM 125, also showed an expression level similar to that of the L. amazonensis, which was lower than the level of expression detected in the homologous L. (S.) tarentolae, ATCC 30267strain (Fig.  3) . This observation may indicate the presence of well-regulated RNA pol I machinery with lineage-specific transcription factors that could interact with the promoter region in each species. Another explanation could be that repressor recognition is stronger in closely-related isolates.
Expression of the CAT reporter that we describe can be credited to a sum of features present in the vector. Our results show that acceptor site features can affect expression in nonpathogenic Leishmania species analyzed, and depending on the acceptor site choice, expression can be almost completely abolished even using a strong RNA pol I promoter region in a heterologous organism (e.g. Fig. 2, L. hoogstraali) . The use of a heterologous promoter to drive transcription proved to be a good strategy for the lizard-infecting group, and correlates with our previous observation that RNA pol I driven expression in heterologous but closer species is higher than in homologous species, as for some species in the Leishmania group (Uliana et al. 1996 , de Andrade Stempliuk & Floeter-Winter 2002 . Although when considering heterologous but distantly related species, such as lizard and mammalian-infecters (Orlando et al. 2002 , Yu et al. 2002 , lack of recognition for the RNA pol I promoter sequence results in a lower level of expression than in the homologous species.
In conclusion, considering non-pathogenic Leishmania as important hosts for the production of proteins of biotechnological and immunological importance, the optimization of trans-splicing acceptor sites and heterologous RNA pol I-driven expression in closer species are important parameters for enhanced protein expression. 
